A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic

por Funk, Colin D., Laferrière, Craig, Ardakani, Ali
Publicado 2020

Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective

por Funk, Colin D., Laferrière, Craig, Ardakani, Ali
Publicado 2021

Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults

por Atwood, Mark, Beausoleil, Linda, Breton, Marie-Claude, Laferriere, Craig, Sato, Reiko, Weycker, Derek
Publicado 2018

A Retrospective Study of the Clinical Burden of Hospitalized All-Cause and Pneumococcal Pneumonia in Canada

por McNeil, Shelly A., Qizilbash, Nawab, Ye, Jian, Gray, Sharon, Zanotti, Giovanni, Munson, Samantha, Dartois, Nathalie, Laferriere, Craig
Publicado 2016

1440. Potential Impact of Routine Use of 13-Valent Pneumococcal Conjugate Vaccine on Hospitalizations for Pneumonia among Older Adults in Canada

por Vojicic, Jelena, Dion, Stephane, Isturiz, Raúl E, Laferriere, Craig, Major, Maria, Nepal, Rajeev M, Suaya, Jose A, McLaughlin, John M
Publicado 2018

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies

por Sings, Heather L, De Wals, Philippe, Gessner, Bradford D, Isturiz, Raul, Laferriere, Craig, McLaughlin, John M, Pelton, Stephen, Schmitt, Heinz-Josef, Suaya, Jose A, Jodar, Luis
Publicado 2019